(Q71864608)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

R Kälviäinen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

M Aikiä

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

E Mervaala

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A M Saukkonen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A Pitkänen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P J Riekkinen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 November 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

291-297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

Computerized neuropsychological assessment of cognitive functioning in children with epilepsy

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

A practical guide for routine EEG studies in epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

Place of newer antiepileptic drugs in the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

Effects of vigabatrin on cognitive function and mood when used as add-on therapy in patients with intractable epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

GABAergic mechanisms in the pathogenesis and treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

Neuropsychological effects of tiagabine, a potential new antiepileptic drug.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

Lack of tolerance to the anticonvulsant effects of tiagabine following chronic (21 day) treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

A Standardized Memory Scale for Clinical Use

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2896%2900084-8

7 January 2021

10.1016/S0920-1211(96)00084-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8956929%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference